Mandate

Vinge advises Cinclus Pharma in connection with listing on Nasdaq Stockholm

Vinge advises Cinclus Pharma Holding AB (publ) (“Cinclus Pharma”) in connection with an offering of new ordinary shares and listing on Nasdaq Stockholm. The first day of trading is 20 June 2024.

The offering will provide Cinclus Pharma with proceeds of approximately SEK 787 million before deduction of issue costs and provided that the over-allotment option is fully exercised. In connection with the offering, Cinclus Pharma also carries out a set-off issue at the offering price to convert outstanding bridge loans. 

Cinclus Pharma is a clinical-stage pharmaceutical company focused on the development of the drug candidate linaprazan glurate, a proprietary “prodrug” of the molecule linaprazan. Linaprazan glurate represents a new and innovative mode of action for the treatment of erosive GERD.

Vinge's team mainly consists of Dain Hård Nevonen,Amanda Knutsson, Anna Svensson,Michaela Ådén and Filip Magnusson (Capital Markets and Public M&A), Stojan Arnestål (IP/Life science), Maria Schultzberg (Corporate taxation), Mathilda Persson (Commercial agreements), Gulestan Ali (Compliance), Nicklas Thorgerzon (IT/GDPR), Jonatan Stentorp (Employment) and Sofia Haggren (Financing).

Related

Vinge advises on the sale of Spring Media to Two Circles

The shareholders of Spring Media have entered into an agreement to sell the shares in Spring Media to Two Circles. Spring Media is an international sports agency operating in, among other things, production, packaging, digital strategies, and rights negotiations in the field of sports rights.
October 28, 2024

Vinge has advised Stendörren Fastigheter in connection with a directed share issue of approximately SEK 505 million

Vinge has advised the property company Stendörren Fastigheter AB (publ) in connection with a directed share issue through which the company raises proceeds of approximately SEK 505 million before transaction costs.
October 25, 2024

Vinge advises Main Capital and Aunetic in connection with the acquisition of Qnister

Vinge has advised Aunetic, a leading governance software specialist, in connection with the acquisition of Qnister AB (“Qnister”). The strategic acquisition enhances Aunetic’s product portfolio and strengthens its presence in the Swedish software compliance market.
October 25, 2024